Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12605000756628Phase 2Completed
Phase 2 trial of atorvastatin in sepsis (2 arms), sponsored by Dr Peter Kruger, Intensive Care Specialist, Princess Alexandra Hospital, Brisbane. Primary endpoint: Incidence of severe sepsis. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12605000756628.